Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || QC Assay Development
- 作者Olivier, Kenneth J.; Hurvitz, Sara A.
- 文件大小194.74KB
- 发表时间2016
- DOI10.1002/9781119060727.ch6
- 页码131-149
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) ||Olivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || IndexOlivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || RadioimmunotherapyOlivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Front MatterOlivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Supplemental ImagesOlivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || QC Assay DevelopmentOlivier, Kenneth J.; Hurvitz, Sara A. · 2016
Antibody-Drug Conjugates (Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer) || Typical Antibody-Drug ConjugatesOlivier, Kenneth J.; Hurvitz, Sara A. · 2016